These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 7526675
1. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Cui G, Sen L, Sager P, Uppal P, Singh BN. Am J Cardiol; 1994 Nov 01; 74(9):896-900. PubMed ID: 7526675 [Abstract] [Full Text] [Related]
2. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Sager PT, Follmer C, Uppal P, Pruitt C, Godfrey R. Circulation; 1994 Oct 01; 90(4):1811-9. PubMed ID: 7923666 [Abstract] [Full Text] [Related]
3. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans. Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN. Circulation; 1993 Sep 01; 88(3):1072-82. PubMed ID: 8353869 [Abstract] [Full Text] [Related]
7. Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia. Boriani G, Biffi M, De Simone N, Bacchi L, Martignani C, Bitonti F, Zannoli R, Butrous G, Branzi A. Pacing Clin Electrophysiol; 2000 Nov 01; 23(11 Pt 2):1935-8. PubMed ID: 11139961 [Abstract] [Full Text] [Related]
8. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia. Kotake Y, Kurita T, Akaiwa Y, Yasuoka R, Motoki K, Kobuke K, Iwanaga Y, Miyazaki S. J Cardiol; 2015 Aug 01; 66(2):161-7. PubMed ID: 25468767 [Abstract] [Full Text] [Related]
9. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease. Martínez-Rubio A, Shenasa M, Chen X, Wichter T, Breithardt G, Borggrefe M. Am J Cardiol; 1994 Feb 15; 73(5):357-60. PubMed ID: 7509121 [Abstract] [Full Text] [Related]
10. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy]. Konecná P, Dvorák R, Semrád B. Vnitr Lek; 1999 Aug 15; 45(8):453-6. PubMed ID: 11045143 [Abstract] [Full Text] [Related]
12. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes. Malik M. Pacing Clin Electrophysiol; 2002 Feb 15; 25(2):209-16. PubMed ID: 11915990 [Abstract] [Full Text] [Related]
16. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone. Brembilla-Perrot B, Claudon O, Houriez P, Beurrier D, Suty-Selton C. Int J Cardiol; 2002 Apr 15; 83(1):47-55. PubMed ID: 11959384 [Abstract] [Full Text] [Related]
18. The antiarrhythmic effects of d-sotalol. Schwartz J, Crocker K, Wynn J, Somberg JC. Am Heart J; 1987 Sep 15; 114(3):539-44. PubMed ID: 3630894 [Abstract] [Full Text] [Related]
19. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol. Hohnloser SH, Zabel M, Just H, Raeder EA. Am J Cardiol; 1993 Feb 15; 71(5):475-8. PubMed ID: 7679244 [No Abstract] [Full Text] [Related]
20. QT dispersion and early arrhythmic risk during acute myocardial infarction. Paventi S, Bevilacqua U, Parafati MA, Di Luzio E, Rossi F, Pelliccioni PR. Angiology; 1999 Mar 15; 50(3):209-15. PubMed ID: 10088800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]